Calycia Bioscience
Salt Lake City, United States · $400K raised
- Headquarters
- Salt Lake City, Utah
- Employees
- 1–10
- Business Model
- B2B
- Website
- calyciabioscience.com
- Total Funding
- $400K
- Last Round
- $400K Pre-SeedJan 2026
- Rounds
- 1
About
CaLycia Bioscience is a Salt Lake City-based biotechnology company, spun out of the University of Utah, developing novel macrophage cell therapies. By leveraging the unique biology of macrophages, the company engineers cells designed to infiltrate, remodel, and treat aggressive solid tumors of the brain via local administration into the central nervous system, bypassing the blood-brain barrier. Its lead intracranial program, CALYM-001, targets glioblastoma, with a second program addressing melanoma brain metastasis.
Summary
Calycia Bioscience is a Biotech company based in Salt Lake City, United States. It has raised $400K in total across 1 round, most recently a $400K Pre-Seed round in Jan 2026. Investors include EPIC Ventures.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2026
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.

Specialty pharmaceutical company
